U.S. allows new flu vaccine from CSL

09/29/2007 | Forbes

The FDA on Friday approved Afluria, a vaccine developed by Australian drugmaker CSL Ltd. to protect people ages 18 and older from type A and B influenza viruses. CSL is poised to supply 2 million doses of Afluria to the U.S. market for the coming flu season.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ